December 9, 2010 (FinancialWire) (Investrend Research Syndicate) (Go to http://www.financialwire.net/?s=rsrchequty+updwngrds for more upgrade/downgrade & research articles.) — ValuEngine, Inc., has upgraded Guangshen Railway Company, Ltd. (GSH – NYSE), OncoGenex Pharmaceuticals, Inc. (OGXI – NASDAQ) and Marshall & Ilsley Corp. (MI – NYSE) to a "5" rating, the service’s highest.

Guangshen Railway Company, together with its subsidiaries, primarily provides passenger and freight transportation services on the Shenzhen-Guangzhou-Pingshi railway in the People's Republic of China. The company was founded in 1996 and is based in Shenzhen, the People's Republic of China. Company summary analytics and an industry research report by ValuEngine on Guangshen Railway is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=GSH).

OncoGenex Pharmaceuticals, a biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of cancer. The company is based in Bothell, Washington. Company summary analytics and an industry research report by ValuEngine on OncoGenex is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=OGXI).

Marshall & Ilsley, through its subsidiaries, provides diversified financial services to corporate, institutional, government, and individual customers in the United States. The company was founded in 1847 and is headquartered in Milwaukee, Wisconsin. Company summary analytics and an industry research report by ValuEngine on Marshall & Ilsley is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=MI).

The ValuEngine Rating is an overall assessment of a stock's attractiveness. It combines the following five factors: ValuEngine’s proprietary valuation, risk-return tradeoff, momentum, market capitalization and ValuEngine’s proprietary forecasted one-month return.

Approximately 80 to 85 companies achieve this highest ValuEngine rating out of VE’s total coverage of over 5,000 publicly traded companies.

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, investment banks and broker-dealers. A special arrangement between the Investrend Research Syndicate and ValuEngine provides for preferred introductions and complimentary value-added services for those enrolling into ValuEngine programs. For more information, including the option to arrange a preferred introduction to ValuEngine, go to ValuEngine’s dedicated Investrend Syndications webpage (at http://www.investrend.com/valuengine).

The Investrend Research Syndicate (http://www.investrend.com/research/syndicate), a proprietary entity of Investrend Communications, Inc., distributes equity research-related information issued by sources deemed to be dedicated to unbiased, reliable and transparent analytics. The primary measure for vetting those sources is the “Standards for Independent Research Providers” (http://www.investrend.com/FIRST/standards) as promulgated by the FIRST Research Consortium (http://www.investrend.com/FIRST).

=========

Equity research on any public company is available through the Shareholders Research Alliance (go to http://www.investrend.com/synd0004 for more information).  Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/).  Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[ftrdnwswnd] [ssryrsyr] [rsrchequty] [vlngnlv] [anlytcsct] [rtngsgnt] [updwngrds]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.